• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自体认知问题与血液或骨髓移植受者的客观认知障碍:一项纵向研究。

Self-endorsed cognitive problems versus objectively assessed cognitive impairment in blood or bone marrow transplantation recipients: A longitudinal study.

机构信息

Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama.

Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, Alabama.

出版信息

Cancer. 2020 May 15;126(10):2174-2182. doi: 10.1002/cncr.32773. Epub 2020 Feb 25.

DOI:10.1002/cncr.32773
PMID:32097508
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7984265/
Abstract

BACKGROUND

Cognitive impairment in survivors of blood or bone marrow transplantation (BMT) is well documented. However, to the authors' knowledge, the clinical relevance of self-endorsed cognitive problems and their relation to objectively assessed cognitive impairment is not known.

METHODS

The authors assessed cognitive impairment in 378 BMT recipients (median age, 52.2 years, 40% of whom were female and 68% of whom were non-Hispanic white) and 98 healthy controls at 5 predetermined time points: at baseline (before BMT) and at 6 months, 1 year, 2 years, and 3 years after BMT. Self-endorsed cognitive problems were evaluated using the Neuropsychological Impairment Scale (NIS) and correlated with a standardized 2-hour battery of objective cognitive testing at each time point. The authors examined the magnitude of difference in self-endorsed cognitive problems between BMT recipients and healthy controls, and the rate of change in scores over time. Multivariable analyses were used to identify clinical and/or demographic variables associated with self-endorsed cognitive problems. The authors also examined the association between cognitive impairment and returning to work after BMT.

RESULTS

Compared with healthy controls, BMT recipients endorsed more cognitive problems (P < .001) at all time points, and the rate of change in NIS scores was found to be significantly greater in BMT recipients. Fatigue was associated with greater endorsement of cognitive problems at 1 year after BMT (odds ratio, 4.23; 95% CI, 2.1-8.3 [P < .001]). Overall, there was a statistically significant, modest correlation noted between self-endorsed cognitive problems and objective cognitive impairment (range, 0.401-0.445 [P ≤ .01]). Higher self-endorsed cognitive problems were associated with a 3.7-fold (P = .02) higher odds of not returning to work at 3 years after BMT.

CONCLUSIONS

The results of the current study demonstrated that self-endorsed cognitive problems can help to identify vulnerable patient subpopulations for detailed cognitive assessment and possible cognitive remediation.

摘要

背景

有大量文献记录了血液或骨髓移植(BMT)幸存者的认知障碍。然而,据作者所知,自我报告的认知问题的临床意义及其与客观评估的认知障碍的关系尚不清楚。

方法

作者在 5 个预定时间点评估了 378 名 BMT 受者(中位年龄 52.2 岁,40%为女性,68%为非西班牙裔白人)和 98 名健康对照者的认知障碍:基线(BMT 前)和 BMT 后 6 个月、1 年、2 年和 3 年。使用神经心理损伤量表(NIS)评估自我报告的认知问题,并在每个时间点与标准化的 2 小时客观认知测试结果相关联。作者比较了 BMT 受者与健康对照者自我报告的认知问题的差异程度,以及随时间变化的评分变化率。多变量分析用于确定与自我报告的认知问题相关的临床和/或人口统计学变量。作者还研究了认知障碍与 BMT 后重返工作的关系。

结果

与健康对照组相比,BMT 受者在所有时间点都报告了更多的认知问题(P<0.001),并且 NIS 评分的变化率在 BMT 受者中明显更高。BMT 后 1 年时,疲劳与更大程度的认知问题报告相关(比值比,4.23;95%置信区间,2.1-8.3[P<0.001])。总体而言,自我报告的认知问题与客观认知障碍之间存在显著、适度的相关性(范围,0.401-0.445[P≤0.01])。更高的自我报告认知问题与 BMT 后 3 年不重返工作的可能性增加了 3.7 倍(P=0.02)。

结论

本研究结果表明,自我报告的认知问题有助于识别脆弱的患者亚群,以便进行详细的认知评估和可能的认知矫正。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cd2/7984265/7a35219899ae/nihms-1674582-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cd2/7984265/1569a501c84c/nihms-1674582-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cd2/7984265/7a35219899ae/nihms-1674582-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cd2/7984265/1569a501c84c/nihms-1674582-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cd2/7984265/7a35219899ae/nihms-1674582-f0002.jpg

相似文献

1
Self-endorsed cognitive problems versus objectively assessed cognitive impairment in blood or bone marrow transplantation recipients: A longitudinal study.自体认知问题与血液或骨髓移植受者的客观认知障碍:一项纵向研究。
Cancer. 2020 May 15;126(10):2174-2182. doi: 10.1002/cncr.32773. Epub 2020 Feb 25.
2
Clinical and Genetic Risk Prediction of Cognitive Impairment After Blood or Marrow Transplantation for Hematologic Malignancy.血液或骨髓移植治疗血液恶性肿瘤后认知障碍的临床和遗传风险预测。
J Clin Oncol. 2020 Apr 20;38(12):1312-1321. doi: 10.1200/JCO.19.01085. Epub 2020 Feb 21.
3
Longitudinal trajectory of frailty in blood or marrow transplant survivors: Report from the Blood or Marrow Transplant Survivor Study.血液或骨髓移植幸存者虚弱的纵向轨迹:来自血液或骨髓移植幸存者研究的报告。
Cancer. 2021 Mar 1;127(5):794-800. doi: 10.1002/cncr.33313. Epub 2020 Nov 18.
4
Assessment of Late Mortality Risk After Allogeneic Blood or Marrow Transplantation Performed in Childhood.儿童异基因造血干细胞或骨髓移植后晚期死亡风险评估。
JAMA Oncol. 2018 Dec 1;4(12):e182453. doi: 10.1001/jamaoncol.2018.2453. Epub 2018 Dec 13.
5
Risk of venous thromboembolism in patients with non-Hodgkin lymphoma surviving blood or marrow transplantation.非霍奇金淋巴瘤患者在接受血液或骨髓移植后发生静脉血栓栓塞的风险。
Cancer. 2019 Dec 15;125(24):4498-4508. doi: 10.1002/cncr.32488. Epub 2019 Aug 30.
6
Pain in older survivors of hematologic malignancies after blood or marrow transplantation: A BMTSS report.血液或骨髓移植后老年血液恶性肿瘤幸存者的疼痛:BMTSS 报告。
Cancer. 2020 Jan 1;126(9):2003-2012. doi: 10.1002/cncr.32736. Epub 2020 Feb 5.
7
Malignant Neoplasms of the Gastrointestinal Tract After Blood or Marrow Transplant.造血干细胞移植后胃肠道的恶性肿瘤。
JAMA Oncol. 2023 Mar 1;9(3):376-385. doi: 10.1001/jamaoncol.2022.6569.
8
Cognitive functioning and quality of life in long-term adult survivors of bone marrow transplantation.骨髓移植成年长期幸存者的认知功能与生活质量
Cancer. 2002 Jul 1;95(1):183-92. doi: 10.1002/cncr.10627.
9
Reintegration after bone marrow transplantation.骨髓移植后的重新整合。
Cancer Pract. 1999 Jul-Aug;7(4):190-7. doi: 10.1046/j.1523-5394.1999.74005.x.
10
Assessing the Risk of Hemorrhagic Complication following Transjugular Liver Biopsy in Bone Marrow Transplantation Recipients.评估骨髓移植受者经颈静脉肝活检后出血并发症的风险。
J Vasc Interv Radiol. 2016 Apr;27(4):551-7. doi: 10.1016/j.jvir.2016.01.007. Epub 2016 Mar 2.

引用本文的文献

1
Sickle Cell Transplantation Evaluation of Long-term and Late Effects Registry (STELLAR) to Compare Long-term Outcomes After Hematopoietic Cell Transplantation to Those in Siblings Without Sickle Cell Disease and in Nontransplanted Individuals With Sickle Cell Disease: Design and Feasibility Study.镰状细胞移植长期和晚期效应登记处(STELLAR):比较造血细胞移植后与无镰状细胞病的兄弟姐妹以及未进行移植的镰状细胞病个体的长期结局:设计与可行性研究
JMIR Res Protoc. 2022 Jul 6;11(7):e36780. doi: 10.2196/36780.
2
Long-term patient-reported neurocognitive outcomes in adult survivors of hematopoietic cell transplant.造血细胞移植后成年幸存者的长期患者报告神经认知结局。
Blood Adv. 2022 Jul 26;6(14):4347-4356. doi: 10.1182/bloodadvances.2021006672.
3

本文引用的文献

1
Cognitive Functioning After Hematopoietic Cell Transplantation for Hematologic Malignancy: Results From a Prospective Longitudinal Study.血液恶性肿瘤患者造血细胞移植后的认知功能:一项前瞻性纵向研究的结果。
J Clin Oncol. 2018 Feb 10;36(5):463-475. doi: 10.1200/JCO.2017.74.2270. Epub 2017 Dec 18.
2
Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults.成人非中枢神经系统癌症相关认知障碍的临床特征、病理生理学及管理
CA Cancer J Clin. 2015 Mar;65(2):123-38. doi: 10.3322/caac.21258. Epub 2014 Dec 5.
3
The effects of cognitive behavioral therapy for postcancer fatigue on perceived cognitive disabilities and neuropsychological test performance.
Neurocognitive Impairment After Hematopoietic Stem Cell Transplant for Hematologic Malignancies: Phenotype and Mechanisms.血液恶性肿瘤造血干细胞移植后神经认知障碍:表型与机制。
Oncologist. 2021 Nov;26(11):e2021-e2033. doi: 10.1002/onco.13867. Epub 2021 Jul 12.
4
Patient-reported cognitive complaints in older adults with gastrointestinal malignancies at diagnosis- Results from the Cancer & Aging Resilience Evaluation (CARE) study.老年胃肠道恶性肿瘤患者诊断时的报告认知主诉 - 来自癌症与衰老韧性评估(CARE)研究的结果。
J Geriatr Oncol. 2020 Jul;11(6):982-988. doi: 10.1016/j.jgo.2020.02.008. Epub 2020 Mar 13.
5
Integrating geriatric assessment into routine gastrointestinal (GI) consultation: The Cancer and Aging Resilience Evaluation (CARE).将老年评估纳入常规胃肠病(GI)会诊:癌症与衰老恢复力评估(CARE)。
J Geriatr Oncol. 2020 Mar;11(2):270-273. doi: 10.1016/j.jgo.2019.04.008. Epub 2019 Apr 18.
癌症后疲劳的认知行为疗法对感知认知障碍和神经心理测试表现的影响。
J Pain Symptom Manage. 2014 Jan;47(1):35-44. doi: 10.1016/j.jpainsymman.2013.02.014. Epub 2013 May 23.
4
Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance.乳腺癌治疗后的认知主诉:检验其与神经心理学测试表现的关系。
J Natl Cancer Inst. 2013 Jun 5;105(11):791-801. doi: 10.1093/jnci/djt073. Epub 2013 Apr 19.
5
Cognitive functioning in allogeneic hematopoietic stem cell transplantation recipients and its medical correlates: a prospective multicenter study.异基因造血干细胞移植受者的认知功能及其医学相关性:一项前瞻性多中心研究。
Psychooncology. 2013 Jul;22(7):1509-16. doi: 10.1002/pon.3159. Epub 2012 Sep 4.
6
Impact of perceived cognitive impairment in breast cancer survivors.乳腺癌幸存者认知障碍感知的影响。
Eur J Oncol Nurs. 2013 Apr;17(2):236-41. doi: 10.1016/j.ejon.2012.06.002. Epub 2012 Aug 14.
7
Symptoms and quality of life in diverse patients undergoing hematopoietic stem cell transplantation.不同造血干细胞移植患者的症状和生活质量。
J Pain Symptom Manage. 2012 Aug;44(2):168-80. doi: 10.1016/j.jpainsymman.2011.08.011. Epub 2012 Jun 13.
8
EEG correlates of fatigue during administration of a neuropsychological test battery.脑电图与神经心理测验组合测试过程中疲劳的相关性。
Clin Neurophysiol. 2012 Feb;123(2):278-84. doi: 10.1016/j.clinph.2011.06.027. Epub 2011 Jul 27.
9
Prospective neurocognitive function over 5 years after allogeneic hematopoietic cell transplantation for cancer survivors compared with matched controls at 5 years.癌症幸存者接受异基因造血细胞移植后 5 年的前瞻性神经认知功能与 5 年时匹配对照者的比较。
J Clin Oncol. 2011 Jun 10;29(17):2397-404. doi: 10.1200/JCO.2010.33.9119. Epub 2011 May 2.
10
Behavioral symptoms in patients with breast cancer and survivors.乳腺癌患者及幸存者的行为症状
J Clin Oncol. 2008 Feb 10;26(5):768-77. doi: 10.1200/JCO.2007.14.3248.